Kyle Faget Interview Highlighted in Digital Health Regulations Year in Review
06 December 2022
MedTech Insight
Foley & Lardner LLP Partner Kyle Faget’s October interview with MedTech Insight is highlighted in their article, “Digital Health Regulations: A Year in Review,” which summarizes both the changes in digital health regulations in 2022 and what medical devices companies should look out for in the coming year.
Faget commented on the impact of the U.S. Food and Drug Administration’s (FDA) Clinical Decision Support Software (CDS) document, saying that some companies had to reevaluate whether their CDS products qualified as a device under the new guidance as the FDA took a broader approach to regulating that what was in its jurisdiction.
To read more about Faget’s earlier comments on this topic, click here.
People
Related News
27 August 2024
In the News
Samuel Goldstick Assesses Data Privacy Challenges for Automakers
Foley & Lardner LLP partner Samuel Goldstick underscored how disclosure can help automakers reduce legal risk in the Automotive Dive article, "Automakers face growing data privacy challenges, experts say."
26 August 2024
In the News
Judith Waltz Quoted on Inflation Reduction Act, Pharma Impact
Foley & Lardner LLP partner Judith Waltz is quoted in the PharmaVoice article, "Pharmas’ IRA court losses mount. They keep pursuing them."
20 August 2024
In the News
Kevin Hyde Featured in Q&A on Jacksonville Legal Market – 'The outlook is good'
Foley & Lardner LLP partner Kevin Hyde is featured in a Capital Analytics Associates Q&A on the major achievements of Foley's Jacksonville office, key trends in the legal market, and the firm's commitment to its talent and client service.